Tailored Patient Navigation to Boost Lung Cancer Screening in Tribal Communities
Official title: Strengthening Awareness and Community Resources for Early Detection of Lung Cancer Through Navigation Guided Screening Trial (SACRED LUNGS Aims 1.2-3)
Run by Fred Hutchinson Cancer Center · NCT07176000 · Data updated 2026-11-12
This trial tests whether customized patient navigation can help American Indian and Alaska Native people in western Washington start and complete lung cancer screening.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 237 (estimated) |
| Sponsor | Fred Hutchinson Cancer Center Academic / other |
| Locations | 2 sites (Auburn, Washington and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | March 29, 2029 |
| Study ends | April 30, 2029 |
| Registry record updated | October 27, 2026 |
| Trial ID | NCT07176000 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 50–77 with a 20-pack-year smoking history and current tobacco use within the last 15 years who have been seen by a PCP at a participating clinic.
✕Probably not a fit
Individuals not interested in screening or not meeting the smoking history criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants are randomized to receive either tailored patient navigation for 21 months plus an LCS educational handout, or enhanced usual care with a hand-off to discuss LCS followed by 15 months of navigation for those in the second arm. The study uses patient navigation, education, interviews, and surveys to support uptake and follow-up of low-dose CT screening for those aged 50–77 with a 20-pack-year smoking history and recent tobacco use. Settings are two tribal-affiliated clinics in Washington state, with activity spanning clinical staff and patient perspectives. The trial aims to understand how navigation strategies affect screening uptake among AI/AN communities and gather stakeholder insights.
Why it matters
Potential benefit: If successful, tailored navigation could increase lung cancer screening uptake and early detection in tribal communities.
How similar studies have gone: Previous work suggests navigation and targeted outreach can improve screening uptake in underserved populations, but results vary by community and setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Between ages 50-77 * AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Self-reported 20-pack year smoking history * AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Ongoing commercial tobacco use within the past 15 years * AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Seen by a PCP at a participating clinic (South Puget Intertribal Planning Agency \[SPIPA\] or Muckleshoot) within the past three years * Potential participants who want to establish care at an eligible clinic will be connected to a PCP * AIM 2 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: At least 18 years of age * AIM 2 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Affiliation with Muckleshoot or SPIPA (one of the 6 community partnering clinics) as a provider, or supportive staff member * AIM 2 PATIENT SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Patient participated in the aim 1.2 trial * AIM 3 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: At least 18 years of age * AIM 3 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Affiliation with Muckleshoot or SPIPA (one of the 6 community partnering clinics) as a provider, or supportive staff member * AIM 3 PATIENT SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Patient participated in the aim 1.2 trial Exclusion Criteria: * AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Has had a documented chest CT within the past one year * AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Personal history of lung cancer * AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Personal history of any cancer within 5 years except for basal cell or squamous cell skin carcinoma
Where it's running
-
Muckleshoot Tribal Clinic
Auburn, Washington, United States Recruiting -
South Puget Intertribal Planning Agency (SPIPA)
Shelton, Washington, United States Recruiting
Study contacts
- Principal investigator: Matty Triplette, MD, MPH — Fred Hutch/University of Washington Cancer Consortium
- Study coordinator: Matty Triplette, MD, MPH
- Email: mtriplet@fredhutch.org
- Phone: (206) 667-6335
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Couples Coping Together Against Cancer: A Feasibility and Acceptability Look
This observational study tests whether a brokered program for patients with cancer and their partners is feasible and acceptable, and whether it may reduce distress over time.
-
Lung Toolkit: a tailored education program to help AI/AN cigarette smokers learn about lung cancer and screening
A Lung Toolkit education program is tested to see if it improves knowledge about lung cancer and screening among American Indian and Alaska Native cigarette smokers aged 50–80.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
Restorative Justice–Based Lung Cancer Screening Support for Black Individuals to See if Screening Increases Uptake
This trial tests a restorative justice–based decision-making support to see if it increases lung cancer screening among Black adults who smoke or recently stopped.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Support for Veterans with lung cancer.
This study will test whether weekly phone support from a trained lay health worker can improve quality of life for Veterans who are newly diagnosed with lung cancer or who finished treatment within the past year.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.